Previous 10 | Next 10 |
home / stock / bmymp / bmymp news
BMY is one of the best dividend growth healthcare stocks you can find today. What are shares worth today? We detail our full valuation model. For further details see: Bristol Myers Squibb: Buy, Hold, Or Sell This Dividend Growth Healthcare Stock?
David Abrams’ 13F portfolio value increased ~25% this quarter from $3.55B to $4.44B. The number of positions decreased from 17 to 16. Abrams Capital Management added Change Healthcare while dropping TransMedics Group during the quarter. The top three positions are Lithia Mo...
Bristol-Myers Squibb Company (BMY) Bernstein’s 37th Annual Strategic Decisions Conference Call June 2, 2021 10:00 ET Company Participants Giovanni Caforio - Chief Executive Officer Nina Goworek - Investor Relations Conference Call Participants Aaron Gal - Sanford C. Bernstein Presentat...
Dividend portfolios remain what I see as one of the best ways to invest your money for growth and returns. This month, over $6,300 came in from my core portfolio. The market seems to have found a bit of a top for the time being. Both my domestic and international portfolio has moved o...
My monthly review of DivGro provides a summary of transactions and explains how those transactions affect projected annual dividend income. DivGro is my portfolio of dividend growth stocks. In May, I added shares to one existing position and I reduced the size of one existing position...
This article presents the top 50 holdings of 50 dividend-paying ETFs. Apple and Microsoft top the list, as they did one year ago. I include a table with key metrics of interest to dividend growth investors. Part 2 of this article will showcase the top 7 stocks in each GICS sec...
Market leadership by sector and market cap. Sectors remain tilted toward mid-cycle ideas. However, stock-specific ideas are available in every basket. For further details see: The Top Stocks You Can Buy Now
Chinese private equity firm Wise Road Capital is acquiring Magnachip. Reports about authorities potentially disrupting the deal are surfacing with some regularity. These reports are not new and there have been other trial balloons. If the deal fails, the result may not be as b...
Bristol-Myers Squibb Company (BMY) 2021 UBS Global Healthcare Virtual Conference Call May 25, 2021 13:00 ET Company Participants David Elkins - Executive Vice President & Chief Financial Officer Samit Hirawat - Executive Vice President & Chief Medical Officer Conference Call Participa...
Halozyme is currently in the stalwart phase with approximately less than 50% more upsides. The company shifted focus to employing a low-risk business model. They're out-licensing their Enhanze technology to other large pharmas. With an increasing number of blockbusters being refor...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb $2Pr Company Name:
BMYMP Stock Symbol:
OTCMKTS Market:
Bristol-Myers Squibb $2Pr Website: